The global defibrillators market would reach $15,610 million by 2022. Defibrillators are devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse. Growing focus towards public access defibrillator (PAD) by the public & private organizations has fueled the market growth. read more at: https://www.alliedmarketresearch.com/defibrillator-market

1. DEFIBRILLATORS
MARKET
Global Opportunity Analysis and
Industry Forecasts,
2014 - 2022
Pages: 150
Published: 2016

2. DEFIBRILLATORS MARKET
OVERVIEW
• Defibrillation is a common treatment for life-threatening cardiac dysrhythmias
and ventricular fibrillation. Defibrillation consists of delivering a therapeutic dose
of electric current to the heart with a device called a defibrillator.
• The global defibrillators market would reach $15,610 million by 2022.
Defibrillators are devices used to deliver therapeutic shock to a patient’s heart in
life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia,
and pulseless ventricular tachycardia.
• The global defibrillators market would reach $15,610 million by 2022.
Read more about report at: https://www.alliedmarketresearch.com/defibrillator-
market

3. DEFIBRILLATORS MARKET
KEY FINDINGS
• In 2015, T-ICDs led the overall implantable defibrillator market revenue, and is
projected to grow at a CAGR of 4.9% during the forecast period.
• Fully-automated defibrillator segment is projected to grow at a CAGR of 9.9%
during the analysis period.
• The automated external defibrillator (AEDs) is projected to generate the largest
revenue in the external defibrillator market.
Get sample copy of report at: https://www.alliedmarketresearch.com/request-
free-sample/1434

4. KEY BENEFITS OF THE
REPORT
• The study provides an in-depth analysis of the world neuromodulation market
with current trends and future estimations to elucidate the imminent investment
pockets.
• The report provides a quantitative analysis from 2014 to 2022, which is expected
to enable the stakeholders to capitalize on prevailing market opportunities.
• The report provides actual historical figures for 2014 and 2015 and provides Y-o-Y
forecasts for 2016 to 2022, considering 2015 as base.
• SWOT analysis studies the internal environment of the leading companies for
strategy formulation.

5. DEFIBRILLATORS MARKET
SEGMENTS

6. KEY DRIVERS OF THE
DEFIBRILLATORS MARKET
Increasing adoption of technologically
advanced defibrillators.
Growing demand for quality medical care
High incidences of SCA

7. KEY PLAYERS IN INDUSTRY
• ZOLL Medical Corporation
• Stryker Corporation
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• LivaNova PLC
• Medtronic plc
• Koninklijke Philips N.V.
• Defibtech, LLC
• St. Jude Medical, Inc.
• Nihon Kohden Corporation
• Cardiac Science Corporation

8. ASIA PACIFIC: MOST
LUCRATIVE
DEFIBRILLATORS MARKET

9. DEFIBRILLATORS MARKET
“North America accounted for the majority of revenue in 2015 and is expected to
maintain its dominance throughout the forecast period. This is attributed to the
increased adoption of advanced defibrillators, increased awareness about public
access defibrillator, increased procedure volumes resulting from rapidly aging
population, and increasing incidence of cardiovascular diseases and sudden cardiac
arrest (SCA). Moreover, improvement in healthcare expenditure further boosts the
sale of home care defibrillators such as wearable external defibrillators and
automated external defibrillator (AEDs).”
Garima Chandra

10. DEFIBRILLATORS MARKET BY
REGION
North America, Europe, Asia-Pacific, LAMEA

11. Follow Us On
Thank You!
For More Details
Visit us at
https://www.alliedmarketresearch.com/defibrillator-market